SCHEMBL7363099

SCHEMBL7363099

CC(C)Oc1ccc(NC(=O)c2c[nH]c3c2C(=O)CCC3)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 9/20 0.46
NR4A2 P43354 6/20 0.46
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
ABCB1 P08183 1/20 0.36
GAA P10253 2/20 0.35
POLB P06746 1/20 0.35
JMJD7 P0C870 1/20 0.35
NR4A1 P22736 1/20 0.35
NR4A3 Q92570 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
MET P08581 2/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400116 0.90 DHODH (0.47) DHODHNR4A2NPC1RAB9ASMN1; SMN2
SCHEMBL7359461 0.88 DHODH (0.44) DHODHNR4A2NPC1RAB9ASMN1; SMN2
SCHEMBL7363435 0.87 DHODH (0.41) DHODHNR4A2LMNAPOLBMAPT
SCHEMBL7367658 0.85 PNLIP (0.46) NPC1RAB9ASMN1; SMN2LMNAGAA
SCHEMBL7364226 0.85 TP53 (0.42) DHODHNR4A2NPC1RAB9ASMN1; SMN2
SCHEMBL7367023 0.84 MAPT (0.41) NPC1RAB9ALMNAMAPT
SCHEMBL6092550 0.84 DHODH (0.39) DHODHNR4A2NPC1RAB9ASMN1; SMN2
SCHEMBL7365392 0.83 XDH (0.45) DHODHNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6092670 0.82 DHODH (0.42) DHODHNR4A2NPC1RAB9ASMN1; SMN2
SCHEMBL6094311 0.82 DHODH (0.43) DHODHNR4A2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0725775-B1 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 1998-07-22 EP claimed
WO-1998002420-A9 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS 1998-04-23 WO claimed
WO-1998002420-A1 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1998-01-22 WO claimed
EP-0725775-A1 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1996-08-14 EP claimed
WO-1995011885-A1 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1995-05-04 WO claimed
US-5925770-A GAMMA-AMINOBUTYRIC ACID DERIVATIVES FOR DIAGNOSIS OR TREATMENT OF ANXIETY, SLEEP DISORDERS, SEIZURES, OVERDOSES OF BENZODIAZEPINE TYPE DRUGS, COGNITION ACTIVATORS NEUROGEN CORPORATION (US) 1999-07-20 US disclosed
EP-0725775-B1 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 1998-07-22 EP disclosed
US-5750702-A Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1998-05-12 US disclosed
WO-1998002420-A9 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS 1998-04-23 WO disclosed
EP-0825193-A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands NEUROGEN CORPORATION (US) 1998-02-25 EP disclosed
WO-1998002420-A1 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1998-01-22 WO disclosed